Zusammenfassung
Die Pharmakotherapie mit Antacida kann über die nachfolgend aufgeführten Wirkmechanismen die Pathogenese der Refluxkrankheit beeinflussen:
-
a)
Neutralisation des Mageninhalts, Verminderung der Säuremenge und Schmerzlinderung.
-
b)
Adsorption von Gallensäuren und Pepsin.
-
c)
Beeinflussung der Magenentleerung.
-
d)
Tonisierung des unteren Oesophagussphincters (UOS).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alfrey AC, Le Grande GR, Kaehny WD (1976) The dialysis encephalopathy syndrome. N Engl J Med 294: 184–188
Becker G, Overhoff H, Forth W (1979) Ist Aluminium ungiftig? Dtsch Ärztebl 76: 1639 1642
Behar J, Sheahan DG, Biancani P, Spiro HM, Storer EH (1975) Medical and surgical management of reflux esophagitis. A 38-month report on a prospective clinical trial. N Engl J Med 293: 263–268
Blum AL, Siewert R (1977) Hiatushemie, Refluxkrankheit and Refluxösophagitis. Internist 18: 423–435
Boyes BE, Woolf IL, Wilson RY, Cowley DJ, Dymock IW (1975) Treatment of gastric ulcer with a bismuth preparation. Postgrad Med J [Suppl 5] 51: 29
Clain JE, Malagelada JR, Chadvick VS, Hofmann AF (1977) Bindung properties in vitro of antacids for conjugated bile acids. Gastroenterology 73: 556–559
Deering TB, Carlson GL, Malagelada JR, Duenes JA, McCall JT (1979) Fate of oral neutralizing antacid and its effect on postprandial gastric secretion and emptying. Gastroenterology 77: 986–990
Earlam RJ (1972) Further experience with epigastric pain reproduction test in duodenal ulceration. Br Med J II: 683
Eckardt V, Holtermüller KH (1975) Effect of pentagastrin and gastric alkalinization on lower esophageal sphincter pressure in diffuse esophageal spasm. Digestion 13: 1–7
Fordtran JS (1968) Acid rebound. N Engl J Med 279: 900–905
Fordtran JS, Collyns AH (1966) Antacid pharmacology in duodenal ulcer. N Engl J Med 274: 921–927
Fordtran JS, Morawsky SG, Richardson CT (1973) In vivo and in vitro evaluation of liquid antacids. N Engl J Med 288: 923–928
Goldberg HI, Dodds WJ, Gee S, Montgomery C, Zboralske AF (1969) Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 56: 223–230
Goldenberg M, Honkomp LJ, Burrous SE, Gastellion AW (1975) Protective effect of pepto-bismol liquid on the gastric mucosa of rats. Gastroenterology 69: 636–640
Goyal RK, McGuigan J (1974) Is gastrin a major determinant of basal lower esophageal sphincter pressure?: a double blind controlled study using high titer gastrin antiserum. J Clin Invest 57: 291–300
Hava M, Hurwitz A (1973) The relaxing effect of aluminium and lanthanum on rat and human gastric smooth muscle in vitro. Eur J Pharmacol 22: 156–161
Higgs RH, Smyth RD, Castell DO (1974) Gastric alkalinization effect on lower-esophageal-sphincter pressure and serum gastrin. N Engl J Med 291: 486–490
Holtermüller KH (1979) Renaissance der Antazida? Dtsch Ärztebl 47: 3117–3123
Holtermüller KH, Büchler R, Sinterhauf K (1975) Die Wirkung von oralem Calcium and Magnesium auf die Magensäuresekretion and Gastrinfreisetzung bei Patienten mit Ulcus duodeni. Verh Dtsch Ges Inn Med 81: 1237–1238
Holtermüller KH, Bohlen E, Castro M, Weis HJ (1977) Überlegungen zur Therapie mit Antacida. Med Klin 72: 1229–1241
Hurwitz A, Robinson RG, Vats TS, Whittier FC, Herrin WF (1971) Effects of antacids on gastric emptying. Gastroenterology 71: 268–273
Kline MM, McCallum RW, Curry N, Sturdevant RAL (1975) Effect of gastric alkalinization on lower esophageal sphincter pressure and serum gastrin. Gastroenterology 68: 1137–1139
Koelz HR, Lepsien G, Hollinger AP, Säuberli H, Largiader F, Arnold R, Blum AF, Siewert R (1978) Effect of intraduodenal peptone on the lower esophageal sphincter pressure in the dog. Gastroenterology 75: 283–285
Krejs GJ, Seefeld U, Brändli H, Bron BA, Caro G, Schmid P, Blum AL (1970) Gastrooesophageal reflux disease: correlation of subjective symptoms with 7 objective oesophageal function tests. Acta Hepatogastroenterol (Stuttg) 23: 130–149
Kunert H, Ottenjann R (1979) Effekt eines Mg-Al-hydroxid-haltigen Antazidums auf die Heilungsdauer von Ulcera duodeni–randomisierte Doppelblindstudie. Z Gastroenterol 22: 630–631
Malagelada JR, Phillips SF, Higgins JA, Shorter RG, Heerden JA van, Adson MA (1979) A prospective evaluation of alkaline reflux gastritis: bile acid binding agents and Roux-Y-diversion. Gastroenterology 76: 1192
McHardy G (1979) A multicentric, randomized clinical trial of Gaviscon in Reflux Esophagitis. South Med J [Suppl 1] 71: 16–21
Peterson WL, Sturdevant RAL, Frankl HD, Richardson C, Isenberg JI, Elashoff JD, Sones JQ, Gross RA, McCallum RW, Fordtran JS (1977) Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297: 341–345
Petrokubi RJ, Jefries GH (1979) Cimetidine versus Antacid in Scleroderma with Reflux Esophagitis. A randomized double-blind controlled study. Gastroenterology 77: 691–695
Salmon PR, Brown P, Williams R, Read AE (1974) Evaluation of colloidal bismuth ( De-nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up. Gut 15: 189–193
Stanciu C, Bennett JR (1974) Alginate/Antacid in the reduction of gastro-oesophageal reflux. Lancet I: 109–111
Wenger J, Sundy M (1972) Pepsin adsorption by commercial antacid mixtures. In vitro study. J Clin Pharmacol 12: 136–141
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Holtermüller, K.H. (1981). Antacida. In: Siewert, J.R., Blum, A.L. (eds) Refluxtherapie. Interdisziplinäre Gastroenterologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67714-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-67714-4_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-10179-6
Online ISBN: 978-3-642-67714-4
eBook Packages: Springer Book Archive